8-K/A

AMENDMENT NO.1 TO FORM 8-K

Company: Oruka Therapeutics, Inc.
Filed: October 28, 2008
Period of Report: May 1, 2008
Accession Number: 0001193125-08-218001

View Document ↗ View on SEC.gov ↗